Catalyst Wire Dossier Catalyst Wire Dossier

Treprostinil (inhaled)

treprostinil · United Therapeutics Corporation
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Treprostinil (inhaled), covering 2017-04-11 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD [Phase 2]

See pricing